Nicole Lulkin

Subgenomic SARS-CoV-2 replicon and reporter replicon cell lines enable ultrahigh throughput antiviral screening and mechanistic studies with antivirals, viral mutations or host factors that affect COVID-19 replication

S. Sarafianos, Haijuan Du, Philip R. Tedbury, 2021, bioRxiv.

Nirmatrelvir Resistance in SARS-CoV-2 Omicron_BA.1 and WA1 Replicons and Escape Strategies

S. Sarafianos, Huanchun Zhang, S. Lan, 2023, bioRxiv.